4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000899243-23-003948
Chief Operating Officer sold 3,394 shares at $1.86 ($6,313)
- Chief Operating Officer acquired 265,957 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Keutzer Timothy Chief Operating Officer | 2023-02-01 | Grant or award | +265,957 | 330,538 | D | ||
| Keutzer Timothy Chief Operating Officer | 2023-02-02 | Sale | −3,394 | $1.86 | $6,313 | 327,144 | D |
| Open-market sales · 3,394 sh · avg $1.86 · $6,313 | |||||||
Loading xslF345X03/doc4.xml…